Utah Medical Products (UTMD) announces that its board of directors has appointed Kevin C. Timken, Esq to its board. In addition, the board approved a quarterly cash dividend of 31c per share of common stock payable on January 5 to shareholders of record at the close of business on December 16. This is a 1.6% increase over the prior regular quarterly cash dividend.
Meet Samuel – Your Personal Investing Prophet
- Start a conversation with TipRanks’ trusted, data-backed investment intelligence
- Ask Samuel about stocks, your portfolio, or the market and get instant, personalized insights in seconds
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on UTMD: